Cross-Cell-Line Analysis Identifies a Shared SLC6A8 Depletion Signature Associated with Hypoxia-Related Expression in Hepatocellular Carcinoma
Genes · 07.11.2026 · 17 (11) · 1404
DOI: 10.3390/genes17111404 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, online erschienen am 07.11.2026. Verfasst von Amna Rasheed und 1 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gansu Haizhi base project.
Abstract (Originalsprache)
Background/Objectives: SLC6A8-mediated creatine transport has been implicated in hypoxic adaptation in hepatocellular carcinoma (HCC), but the consistency of its downstream transcriptional response across cellular backgrounds remains unclear.
Methods
We reanalyzed RNA sequencing data from SLC6A8-depleted Hep3B and Huh7 cells using limma–voom, interaction testing and inverse-variance effect synthesis, followed by gene set testing, regulatory activity inference, and clinical cohort analysis.
Results
The genome-wide effects were poorly concordant (Spearman ρ = 0.010). A selected cross-model signature contained 501 genes; removing the interaction screen expanded it to 708 genes, including all 501 primary genes. Twenty-nine pathways were directionally concordant, and inferred hypoxia activity was consistently reduced. In TCGA-LIHC and GSE14520, SLC6A8 expression correlated positively with a non-overlapping hypoxia score and inversely with the depletion signature. The signature was associated with lower mortality in the adjusted TCGA analysis, but the external survival validation in GSE14520 was nonsignificant (219 patients; 84 deaths; hazard ratio per standard deviation, 0.851; 95% confidence interval, 0.702–1.032). It is therefore not a validated clinical biomarker.
Conclusions
The sensitivity analyses supported consistent inverse SLC6A8 associations, whereas the hypoxia and survival findings depended partly on signature definition and platform coverage. The results identify a limited cross-model transcriptional signature associated with SLC6A8 depletion that correlates with hypoxia-related expression in patient cohorts. The mechanistic and therapeutic interpretations remain hypothesis-generating.
Förderung
- Gansu Haizhi base project
Zitieren
APA
Rasheed, A., & Xie, X. (2026). Cross-Cell-Line Analysis Identifies a Shared SLC6A8 Depletion Signature Associated with Hypoxia-Related Expression in Hepatocellular Carcinoma. Genes, 17(11), 1404. https://doi.org/10.3390/genes17111404
Vancouver
Rasheed A, Xie X. Cross-Cell-Line Analysis Identifies a Shared SLC6A8 Depletion Signature Associated with Hypoxia-Related Expression in Hepatocellular Carcinoma. Genes. 2026;17(11):1404. doi:10.3390/genes17111404
BibTeX
@article{Rasheed2026,
author = {Rasheed, Amna and Xie, Xiaodong},
title = {Cross-Cell-Line Analysis Identifies a Shared SLC6A8 Depletion Signature Associated with Hypoxia-Related Expression in Hepatocellular Carcinoma},
journal = {Genes},
year = {2026},
volume = {17},
number = {11},
pages = {1404},
doi = {10.3390/genes17111404}
}
EUVIMED